{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:24:56Z","timestamp":1777328696321,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.yebeh.2020.107546","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T22:41:11Z","timestamp":1610577671000},"page":"107546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Aggression as psychiatric side effect of newer AEDs in patients with epilepsy: Cross-sectional study based on Buss-Perry Aggression Questionnaire"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0965-5092","authenticated-orcid":false,"given":"Mihoko","family":"Kawai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Goji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Kanemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107546_b0005","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107546_b0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eplepsyres.2016.08.001","article-title":"Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: the FYDATA study","volume":"126","author":"Villanueva","year":"2016","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107546_b0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2006.08.008","article-title":"Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy","volume":"10","author":"Weintraub","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107546_b0020","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/epi.12212","article-title":"Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies","volume":"4","author":"Steinhoff","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107546_b0025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/01.WNL.0000103282.62353.85","article-title":"Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy","volume":"62","author":"Boylan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107546_b0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107546_b0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","article-title":"The aggression questionnaire","volume":"63","author":"Buss","year":"1992","journal-title":"J Person Soc Psychol"},{"key":"10.1016\/j.yebeh.2020.107546_b0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4992\/jjpsy.70.384","article-title":"Development of the Japanese version of the Buss-Perry Aggression Questionnaire (BAQ)","volume":"70","author":"Ando","year":"1999","journal-title":"Jpn J Psychol"},{"key":"10.1016\/j.yebeh.2020.107546_b0045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0005-7967(00)00057-7","article-title":"Psychometric evaluation on the Japanese adaptation of the Aggression Questionnaire","volume":"39","author":"Nakano","year":"2001","journal-title":"Behav Res Ther"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107546_b0050","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1528-1167.2008.01792.x","article-title":"Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy","volume":"50","author":"Labiner","year":"2009","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107546_b0055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.yebeh.2008.05.012","article-title":"Positive and negative psychotropic effects of levetiracetam","volume":"13","author":"Helmstaedter","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107546_b0060","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1517\/14656566.6.8.1401","article-title":"Lamotrigine in the treatment of bipolar disorder","volume":"6","author":"Bhagwagar","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.yebeh.2020.107546_b0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yebeh.2006.09.008","article-title":"Effect of lamotrigine on depressive symptoms in adult patients with epilepsy","volume":"10","author":"Ettinger","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107546_b0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-1014497","article-title":"Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study","volume":"23","author":"Okuma","year":"1990","journal-title":"Pharmacopsychiatry"},{"issue":"7","key":"10.1016\/j.yebeh.2020.107546_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072143","article-title":"A history of the pharmacological treatment of bipolar disorder","volume":"19","author":"L\u00f3pez-Mu\u00f1oz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2020.107546_b0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1994.tb01640.x","article-title":"Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients","volume":"89","author":"Pulliainen","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2020.107546_b0085","first-page":"541","article-title":"Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine","volume":"96","author":"Friedman","year":"1992","journal-title":"Am J Ment Retard"},{"key":"10.1016\/j.yebeh.2020.107546_b0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yebeh.2017.10.032","article-title":"Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study","volume":"79","author":"Rocamora","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107546_b0095","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/epi.13054","article-title":"Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel","volume":"56","author":"Ettinger","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2020.107546_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2019.02.009","article-title":"The effect of perampanel on aggression and depression in patients with epilepsy: A short-term prospective study","volume":"67","author":"Goji","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107546_b0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107546_b0110","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.2174\/138161212803523563","article-title":"Lack of data on depression-like states and antidepressant pharmacotherapy in patients with epilepsy: randomised controlled trials are badly needed","volume":"18","author":"Kanemoto","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107546_b0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yebeh.2011.03.015","article-title":"Lamotrigine improves aggression in patients with temporal lobe epilepsy","volume":"21","author":"Kato","year":"2011","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107546_b0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1620\/tjem.232.123","article-title":"Anger is a distinctive feature of epilepsy patients with depression","volume":"232","author":"Mori","year":"2014","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.yebeh.2020.107546_b0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.seizure.2015.07.004","article-title":"The adverse event profile of levetiracetam: a meta-analysis on children and adults","volume":"31","author":"Verrotti","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107546_b0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1525-5050(03)00005-2","article-title":"A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials","volume":"4","author":"De","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107546_b0135","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107546_b0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yebeh.2018.01.001","article-title":"Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study","volume":"80","author":"Liguori","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"18","key":"10.1016\/j.yebeh.2020.107546_b0145","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107546_b0150","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40263-013-0091-9","article-title":"Systematic review and meta-analysis of the efficacy and safety of perampanel in the treatment of partial-onset epilepsy","volume":"27","author":"Hsu","year":"2013","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107546_b0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1994.tb01640.x","article-title":"Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients","volume":"89","author":"Pulliainen","year":"1994","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107546_b0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1528-1157.2001.09000.x","article-title":"Reexamination of interictal psychoses based on DSM IV psychosis classification and international epilepsy classification","volume":"42","author":"Kanemoto","year":"2001","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020307265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020307265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:34:40Z","timestamp":1761503680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020307265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"alternative-id":["S1525505020307265"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107546","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggression as psychiatric side effect of newer AEDs in patients with epilepsy: Cross-sectional study based on Buss-Perry Aggression Questionnaire","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107546"}}